
Cipla Limited has informed the Exchange regarding a press release dated May 10, 2021, titled "Cipla enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India ".
Filed with NSE ·

Cipla Limited has informed the Exchange regarding a press release dated May 10, 2021, titled "Cipla enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India ".
6ix hasn’t read this filing yet.
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla